Login / Signup

Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer's Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study.

YongSoo Shim
Published in: Current Alzheimer research (2024)
This study shows that only in participants with SCD and MCI, not including AD dementia, can MDS-OAß predict the longitudinal cognitive decline measured by follow-up MMSE. Changes of NfL, not MDS-OAß, parallel the changes of MMSE. Further studies with larger samples and longer durations could strengthen these results..
Keyphrases
  • cognitive decline
  • mild cognitive impairment
  • knee osteoarthritis
  • cognitive impairment